This Apple Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Oppenheimer analyst Martin Yang downgraded the rating for Apple Inc. AAPL from Outperform to Perform. Apple shares closed at $238.26 on Tuesday. See how other analysts view this stock.
• Goldman Sachs analyst Salveen Richter downgraded Moderna, Inc. MRNA from Buy to Neutral and lowered the price target from $99 to $51. Moderna shares closed at $44.94 on Tuesday. See how other analysts view this stock.
• Keefe, Bruyette & Woods analyst Wood Lay downgraded the rating for Third Coast Bancshares, Inc. TCBX from Outperform to Market Perform but raised the price target from $40 to $42. Third Coast Bancshares shares closed at $37.05 on Tuesday. See how other analysts view this stock.
• HC Wainwright & Co. analyst Swayampakula Ramakanth downgraded Leap Therapeutics, Inc. LPTX from Buy to Neutral. Leap Therapeutics shares closed at $0.65 on Tuesday. See how other analysts view this stock.
• Stifel analyst Brad Reback downgraded the rating for Datadog, Inc. DDOG from Buy to Hold and lowered the price target from $165 to $140. Datadog shares closed at $151.89 on Tuesday. See how other analysts view this stock.

Considering buying AAPL stock? Here’s what analysts think:

Read This Next:

• How To Earn $500 A Month From Meta Platforms Stock Ahead Of Q4 Earnings